FeesSafety
Pluang+

Fennec Pharmaceuticals Q3 2026 sales jump 56% to $19.4M, with record cash flow and patient growth.

Company Fundamentals
12 Nov 2026, 13:03 WIB
GlobeNewsWire
View Source
Bullish
Fennec Pharmaceuticals Q3 2026 sales jump 56% to $19.4M, with record cash flow and patient growth.

Fennec Pharmaceuticals reported a 56% year-over-year increase in Q3 2026 net product sales to $19.4 million, driven by strong demand for PEDMARK®. The company achieved a non-GAAP adjusted EBITDA of $5.8 million and grew its cash position to $48.7 million, supported by positive operational cash flow. Continued commercial expansion and clinical data supporting PEDMARK®'s efficacy in preventing hearing loss in pediatric cancer patients underpin the growth. Fennec plans to maintain disciplined capital deployment and expects ongoing demand growth into 2027.

Fennec Pharmaceuticals' Q3 2026 financial results provide context for readers following health sector stocks. On Pluang, 88 of 150 priced health-sector US stocks rose while 55 fell as of Nov 12, 2026 16:41 WIB. Notable movers include SANA at USD 2.41 with a 5.24% increase and 94% buy order activity, BNGO at USD 1.15 up 4.55%, and MMED at USD 17.50 down 4.11%.

More News

Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...

Market News
Bullish
59 minutes ago
Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings announced its third quarter 2026 financial results, reporting total revenues of $753.9 million and an adjusted EBITDA of $110.4 million, reflecting a 23% increase year-over-year on a combined basis. The company completed a merger wi...

Company Fundamentals
Neutral
59 minutes ago
Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining reported a 146% increase in nine-month Adjusted EBITDA to $19.8 million, driven by a 38% rise in revenue to $67.9 million. Despite some production delays, zinc output is expected to improve in Q4 2026. The company is progressing its U.S....

Company Fundamentals
Bullish
59 minutes ago
Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

A new report from Fiverr reveals that 81% of full-time U.S. employees want to become their own boss, with 42% prioritizing independence over higher pay. This trend, dubbed "The Great Flexit," shows workers quietly preparing to freelance by building A...

Market News
Bullish
59 minutes ago
KBR to spin off Trinzic in Jan 2027, launching with $5B revenue in national security and tech markets

KBR to spin off Trinzic in Jan 2027, launching with $5B revenue in national security and tech markets

KBR announced the planned spin-off of its Mission Technology Solutions business into a new independent company named Trinzic, set to launch in January 2027. Trinzic will operate in national security, space, and technology sectors with over $5 billion...

Company Fundamentals
Bullish
59 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App